Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.
Infectious complications of immune checkpoint inhibitors in solid organ malignancies.
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Infectious complications of immune checkpoint inhibitors in solid organ malignancies.
Infectious complications of immune checkpoint inhibitors in solid organ malignancies. Cancer Med. 2022 01; 11(1):21-27.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Bacterial Infections
Carcinoma, Non-Small-Cell Lung
Carcinoma, Renal Cell
Female
Humans
Kidney Neoplasms
Lung Neoplasms
Male
Melanoma
Middle Aged
Neoplasms
Retrospective Studies
Risk Factors
Virus Diseases
Young Adult
authors with profiles
Ravi Salgia